David F. Adams

Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor–Prolyl Hydroxylase Inhibitor for Anemia

Jennifer L. Ariazi, Kevin J. Duffy, David F. Adams et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 89 citations · Full text

Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor

David F. Adams, Mark S. Watkins, Luc Durette et al. · Toxicologic Pathology · 2019 · 27 citations

Non-invasive monitoring of pharmacodynamics during the skin wound healing process using multimodal optical microscopy

Jose J. Rico-Jimenez, Jang Hyuk Lee, Aneesh Alex et al. · BMJ Open Diabetes Research & Care · 2020 · 18 citations · Full text

p38 MAPK Inhibitors Ameliorate Target Organ Damage in Hypertension: Part 2. Improved Renal Function as Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Stephen C. Lenhard, Sandhya S. Nerurkar, Thomas Schaeffer et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 17 citations